Why we bought more Danaher even after it lowered the forecast for a key business

  • 📰 CNBC
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 72%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

Stocks tend to bottom before their industry cycle does, and Danaher is almost there.

Danaher delivered beats on the top and bottom lines for the third quarter on Thursday. But shares of the life sciences and medical diagnostics company remain under pressure after management was forced to lower expectations for one of its key businesses. Revenue for the period ended Sept. 30 declined 11.5% organically year over year to $6.87 billion, outpacing analyst estimates of $6.63 billion, according to Refinitiv. When excluding the 8.

Driving this forecast is an expectation for biotechnology sales to be down in the high-teens percentage range, life sciences sales to be about flat , and for diagnostics to be down in the mid-teens percentage point range. The adjusted operating profit margin is expected to be 29% — slightly better than the Street's 28%.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 12. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Danaher Tops Earnings and Revenue Estimates. The Stock Is Rising.Danaher posts third-quarter earnings of $2.02 a share on revenue of $6.87 billion.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

U.S. stocks open lower after 10-year Treasury yield tops 5% for first time since 2007Isabel Wang is a Markets Reporter for MarketWatch.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

Stocks Poised to Open HigherThis week features a smattering of earnings from Big Tech companies as well as GDP and inflation reports.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »

Stocks extend slide, Chevron mega-deal, Apple slumps, 2-year auction on deck, Roivant drug saleStocks slide, Chevron mega-deal, Apple, 2-year auction, Roivant drug sale
Bron: startelegram - 🏆 248. / 63 Lees verder »

Too Much Value Concentrated in Seven US StocksTo say that the US markets are top-heavy is an understatement.
Bron: Newsweek - 🏆 468. / 52 Lees verder »

Salesforce, Unity see their stocks fall after Piper Sandler abandons bullish stanceEmily Bary is a MarketWatch news editor based in New York.
Bron: MarketWatch - 🏆 3. / 97 Lees verder »